2021 IPO

Recursion Pharmaceuticals Stock

Automated drug discovery platform

Sign up today and learn more about Recursion Pharmaceuticals Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Menlo Ventures


Salt Lake City UT, US

Total Funding


About Recursion Pharmaceuticals Stock

Recursion Pharmaceuticals is an automated drug discovery platform. The company combines experimental biology, automation, and artificial intelligence in a parallel system that aims to efficiently identify treatments for any disease which can be modeled at the cellular level. The company uses computer vision to study images of how diseases affect healthy cells and claims to have put together the largest biological image set in the world, as it tracks almost half a million experiments a week. 

Recursion Pharmaceuticals has broadened its platform to probe data from automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. While the company tries to make its own drugs for rare discoveries, it has also sought partnerships with major pharmaceutical companies like Sanofi and Takeda, on other rare diseases, hoping to tackle oncology and inflammation.

The company is headquartered in Salt Lake City, Utah and was founded by Blake Borgeson, Chris Gibson, and Dean Li in 2013. 


Funding History

September 2016$3.5M
September 2016$21.4M
October 2017$60.1M
February 2019$123M
August 2020$308M


Co-Founder and Chief Executive Officer

Chris Gibson

Senior Vice President of Translational Discovery & Chief Evangelist

Ron Alfa

Vice President, Intellectual Property

Kevin Brown

Senior Vice President of Biology

Yolanda Chong

Vice President of Chemistry

Mike Genin

Vice President, Data Science

Imran Haque

Vice President of Finance

Nathan Hatfield

Chief Scientific Officer

Sharath Hegde

Vice President of Business Development & Corporate Initiatives

Matthew Kinn

Chief People Officer

Heather Kirkby

President and Chief Operating Officer

Tina Larson

Vice President, Core Operations

Adeline Low

Vice President of Engineering

Ben Mabey

Vice President of Project Management & Chief of Staff

Kristen Rushton

Chief Technology Officer & Chief Product Officer

Mason Victors


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: